About us

---

Prodessa Pharmaceuticals is a Stockholm-based animal health company, founded in 2025 by researchers from the Karolinska Institutet (Benedict Chambers, PhD), Sweden, and SUNY Upstate New York, USA (William Kerr, PhD). We are driven by our mission, that through dedication, 

innovation and cutting-edge research, be on the frontier in the fight against pet obesity.  Our flagship molecule, K161, will help our companions to live longer and healthier lives, not tomorrow, but today. 

Do you have any questions or would you like to learn more about what we do? Please don’t hesitate to contact us! We look forward to hearing from you!